Blood in 3mL in EDTA. Collect only Mon-Fri. On Fridays, must be received to Burnet lab by 1500.
Minimum Collection Volume
1 mL
Acceptable Specimen Collect Alternatives
4mL DkGr NaHep
8.5mL Yellow A
Shipping/Handling Instructions (Lab Use Only)
Do not spin. Critical: Room Temp
External Client Shipping and Handling
Room temperature only. Must be received in lab within 24 hours of collection.
Stability (from collection to initiation)
Room Temp 24 Hours
Notes
A concurrent CBC/Diff should be drawn with this assay or the results of a concurrent CBC/Diff should be sent so that absolute cell values can be reported.
Immunophenotyping of lymphocytes is performed and results are scored on a 0-4 scale based on different characterization for typical diagnosis, result interpretation is also included
This flow cytometry assay is intended to be used as a screening test. Screening tests are not 100% sensitive nor specific, and a normal result should not preclude molecular sequencing if a patient’s clinical presentation suggests that the probability of a diagnosis is high.
CPT Codes
88184, 88185x10, 88188
Collection
Collect
Blood in 3mL in EDTA. Collect only Mon-Fri. On Fridays, must be received to Burnet lab by 1500.
Minimum Collection Volume
1 mL
Acceptable Specimen Collect Alternatives
4mL DkGr NaHep
8.5mL Yellow A
Shipping/Handling Instructions (Lab Use Only)
Do not spin. Critical: Room Temp
External Client Shipping and Handling
Room temperature only. Must be received in lab within 24 hours of collection.
Stability (from collection to initiation)
Room Temp 24 Hours
Notes
A concurrent CBC/Diff should be drawn with this assay or the results of a concurrent CBC/Diff should be sent so that absolute cell values can be reported.
Immunophenotyping of lymphocytes is performed and results are scored on a 0-4 scale based on different characterization for typical diagnosis, result interpretation is also included
This flow cytometry assay is intended to be used as a screening test. Screening tests are not 100% sensitive nor specific, and a normal result should not preclude molecular sequencing if a patient’s clinical presentation suggests that the probability of a diagnosis is high.
